Equity Buy/Sell (Technical View) Ø 14 Nov: IFCI research

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Equity Buy/Sell (Technical View)

Ø  We have already advised investments in the following scrips which can be accumulated above the levels indicated - As we have been maintaining, it is important to watch Nifty for overall guidance and short term and medium term investors would be well advised to book profits at regular intervals :

o   Alok Ind. > 20/30 ;                           Kotak Bk. > 507 ;                              Glaxo > 2630 ;

o   Gitanjali > 358 ;                               Ambuja Cem. > 165 ;                       JSW Sleel > 661 ;

o    Hind Lever > 401 ;                           M&M > 851 ;

o   TVS Motors > 68.                             Reliance Ind. > 892( it took support around 855 as recommended by us) ;

o    Sun Pharma > 508 ;                        Wipro > 390.

 

COMMODITIES:

 

Ø  Investors would have noted that though gold went past 29000, it could not close beyond. It had reacted by more than Rs.400-500. However, the trend is up and investors could use reactions to 28500/28000 to buy.

 

Have strict stop losses